Browse the evidence

Plant-based proteins (excluding soy) have not been adequately studied for their effect on muscle protein synthesis and appetite in aging adults, though soy appears to have similar appetite-suppressing effects to animal proteins.

While soy protein appears to manage appetite similarly to animal protein, there is insufficient evidence for other plant proteins (like peas or oats) in older adults. Prioritize soy or combine plant sources to ensure adequate amino acids, and monitor appetite to prevent unintended weight loss.

Rapamycin inhibits the Stat3 pathway, which may explain its ability to suppress SASP independently of Nrf2.

Rapamycin may reduce inflammation in aging cells by turning off the Stat3 signal, even if the cell's main antioxidant system (Nrf2) is broken.

Quercetin acts as a SIRT1 activator to mitigate aging-related diseases, including neurodegenerative disorders, by regulating oxidative stress, inflammation, and mitochondrial function.

Quercetin is a natural flavonoid found in foods like onions and grapes that may help protect against age-related brain and body decline by activating the SIRT1 protein. This activation helps reduce inflammation and oxidative stress. While animal studies show promise for conditions like Alzheimer's and Parkinson's, human clinical data is not provided here, so it should be viewed as a potential supportive supplement rather than a cure.

There is currently insufficient evidence from interventional studies to establish a causal link between plant-based diets and improved cognitive function or mental health.

Do not expect plant-based diets to directly improve cognitive function or mental health based on current evidence. While metabolic health improves significantly, the link to brain health remains speculative and requires more research.

Type 2 diabetes is associated with an increased risk of specific cancers, including endometrial, colorectal, breast, pancreatic, liver, and kidney cancers, while being associated with a decreased risk of prostate cancer.

If you have Type 2 diabetes, be aware that your risk for certain cancers (like breast, colorectal, and pancreatic) is higher, while your risk for prostate cancer may be lower. Regular screening appropriate for your age and gender is crucial.

Metformin use in patients with diabetes is associated with a reduced risk of cancer and cancer-specific mortality, although methodological biases in early studies may have inflated these estimates.

If you take Metformin for diabetes, you may benefit from a potential reduction in cancer risk, although this is not yet definitively proven. Continue taking it as prescribed for your diabetes management.

Higher doses (10-15 mg) of the dual GIP/GLP-1 receptor agonist tirzepatide significantly improve specific nonalcoholic steatohepatitis (NASH) biomarkers, including reducing hepatocyte apoptosis (K-18) and fibrosis (Pro-C3), and increasing anti-fibrogenic adiponectin, in patients with type 2 diabetes.

If you have Type 2 Diabetes, higher doses of tirzepatide (10-15 mg weekly) have been shown to improve blood markers associated with liver inflammation and scarring (NASH) compared to placebo. However, this is based on blood tests, not liver biopsies, so it indicates reduced liver stress rather than a confirmed cure for liver disease. Consult your doctor to see if this medication is appropriate for your metabolic health.

Metformin is a common pharmacological insulin sensitization therapy used to treat PCOS, though specific dosing protocols are not detailed in this review excerpt.

Metformin is a standard medication for treating insulin resistance in PCOS. Consult a doctor for appropriate dosing and monitoring.

Aging is a multifactorial biological process driven by interconnected molecular changes across genomics, epigenomics, transcriptomics, proteomics, and metabolomics, which can be mapped and potentially intervened upon through multi-omics analysis.

This paper does not provide a specific user protocol. It establishes that aging is a complex, multi-layered biological process involving genes, proteins, and metabolism, and that scientific databases exist to track these changes across species to develop interventions.

Geroprotective compounds (drugs) alter gene expression and regulation, providing a mechanism for lifespan and healthspan extension.

There are specific drugs (geroprotectors) that change gene expression to potentially extend healthspan. This database catalogs these drugs and their effects, helping researchers find potential treatments.

Experiencing weight bias in primary healthcare negatively influences patient engagement and utilization of health services, leading to avoidance or delay of care.

If you have obesity, you may face weight bias in healthcare, which can lead you to avoid or delay seeking care. This is a common and documented barrier. To overcome this, seek providers who focus on health behaviors rather than just weight, and remember that avoiding care due to fear of judgment can worsen health outcomes.

Ketone bodies (specifically beta-hydroxybutyrate) act as signaling molecules that inhibit histone deacetylases (HDACs) and promote histone acetylation, thereby altering gene expression to support anti-oxidant and anti-inflammatory pathways.

This is a deep molecular mechanism. Practically, it means that the ketone bodies your body makes on a low-carb diet are actively turning on genes that protect your cells from aging and damage.

Activation of the AMPK signaling pathway ameliorates fatty liver disease (FLD) by inhibiting lipid synthesis and promoting fatty acid oxidation.

Supporting liver health involves maintaining cellular energy balance. While specific dietary interventions are not detailed in this mechanism review, the activation of AMPK (often associated with energy deficit or exercise) is a key biological mechanism for reducing liver fat. Focus on metabolic health markers rather than just fat intake.

AMPK activation reduces liver fat accumulation by downregulating lipid synthesis genes (FAS, SREBP-1c, ACC, HMGCR) and upregulating fatty acid oxidation genes (CPT1, PGC1, HSL, ATGL).

Understanding the specific genes involved (like CPT1 for burning fat and FAS for making fat) helps explain why metabolic health is complex. Interventions that activate AMPK can shift this balance.

Ethanol consumption inhibits AMPK activity and reduces CPT1 expression, leading to fatty liver disease.

Chronic alcohol consumption disrupts the liver's ability to regulate fat metabolism by inhibiting AMPK. Reducing alcohol intake may help restore this regulatory pathway.

DNA methylation biomarkers in blood (e.g., ANK1, DAPK1, BDNF) are associated with Alzheimer's Disease (AD) risk and neuropathology, potentially enabling earlier detection.

If you have a family history of Alzheimer's, discuss emerging blood-based epigenetic biomarkers with your doctor. While not yet standard, these tests may offer earlier insights into risk, allowing for proactive lifestyle and medical management.

Gut microbiota depletion (via antibiotics or germ-free conditions) leads to muscle atrophy and reduced physical function, suggesting a causal link between microbiota presence and muscle maintenance.

This finding is primarily relevant for understanding the biological basis of muscle loss. For now, it supports the general importance of a healthy diet for gut microbiota, but does not yet justify specific interventions like antibiotics avoidance for muscle gain in healthy individuals.

Exposure to endocrine-disrupting chemicals (EDCs) during early development can alter adipose tissue homeostasis and energy regulation, predisposing individuals to obesity and metabolic syndrome even with low-calorie diets and increased physical activity.

If you are struggling with weight loss despite diet and exercise, consider your environmental exposure to endocrine disruptors (found in plastics, pesticides, and certain consumer products). While you cannot control all environmental factors, minimizing exposure to plastics (e.g., avoiding heating food in plastic) and choosing fresh over processed foods may support metabolic health, especially if you were exposed to these chemicals during early development.

Exposure to specific endocrine-disrupting chemicals (e.g., phthalates, BPA, vinclozolin) is associated with an increased risk of Testicular Dysgenesis Syndrome (TDS) and reduced male fertility.

For men concerned about fertility, minimizing exposure to known endocrine disruptors like phthalates and BPA (found in some plastics and receipts) is advisable, especially if planning a family. This is particularly relevant for those with a history of reproductive issues, as early developmental exposure may have lasting effects.

Administration of Akkermansia muciniphila improves glucose metabolism and reduces fasting hyperglycemia in type 2 diabetic mouse models by decreasing gluconeogenesis.

Current research shows the bacterium Akkermansia muciniphila improves blood sugar control in diabetic mice, but it is not yet a confirmed or available probiotic treatment for humans.

Mitochondrial fusion is associated with increased longevity and improved metabolic efficiency, whereas unopposed fission (fragmentation) is linked to oxidative stress, reduced ATP production, and accelerated aging phenotypes.

Maintaining mitochondrial health involves supporting the dynamic balance of fusion and fission rather than simply maximizing one process. While specific supplements or exercises are not detailed in this mechanism paper, the evidence suggests that conditions promoting mitochondrial fusion (like moderate caloric restriction or specific genetic pathways) are linked to longevity in model organisms. Focus on general metabolic health markers rather than targeting single mitochondrial proteins in isolation.

Mitophagy, the selective degradation of damaged mitochondria, is a critical quality control mechanism that promotes longevity in model organisms, and its decline contributes to the accumulation of dysfunctional mitochondria in aging.

Supporting mitochondrial quality control through healthy lifestyle habits (like exercise and caloric restriction) may naturally enhance mitophagy, as seen in model organisms. However, since this paper is a mechanism review, specific dosages or supplements for humans are not provided. Focus on maintaining overall metabolic health to support these natural quality control processes.

Smoking cessation during lockdown was observed in 3.3% of smokers, potentially driven by fear of COVID-19 respiratory complications.

For smokers, the heightened awareness of respiratory health risks during the pandemic may serve as a powerful motivator to quit. Leverage this awareness to support cessation efforts.

Rapid Eye Movement (REM) Sleep Behavioural Disorder (RBD), Apnoea, and Long Time in Bed (TIB) are associated with a higher risk of cognitive disorders.

If you have been diagnosed with REM Sleep Behavioural Disorder (RBD), sleep apnoea, or consistently spend excessive time in bed (TIB) without sleeping, these are linked to a higher risk of cognitive decline. Seek medical evaluation and treatment for these conditions as part of your long-term brain health strategy.